The allergy diagnostics market is expanding rapidly due to the growing prevalence of allergic diseases. Additionally, worsening environmental conditions, including declining air quality in ...
Republican Vivek Ramaswamy will launch his bid for Ohio governor on Feb. 24 in his native Cincinnati, with ensuing events in ...
As the Millyard in Manchester emerges as a national hub for research, especially in the biomedical field, the availability of ...
Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...
Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...
The ELISA developed in this study ... 0.5 mM IPTG (isopropyl-β-D-thiogalactopyranoside, Beyotime Biotechnology) was added to induce protein expression. The ultrasonic-disrupted bacterial lysates were ...
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
BEIJING, Feb 14 (Reuters) - China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, corn, and soybean varieties, as part of ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results